BLOG

Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

As Sentinal Diagnostics, we are committed to support healthcare professionals to fight COVID-19 pandemic, thus we have developed two new kits to detect the total antibodies (IgA, IgG and IgM) against Spike and Nucleocapside proteins of SARS-CoV-2. COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab assays are In Vitro Diagnostic tests, for quantitative and […]

READ MORE "Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19"




UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

As Sentinel Diagnostics we are constantly working from the beginning of the COVID-19 pandemia providing high quality test for SARS-CoV-2 detection. Recently new virus variants appeared, such as the UK variant (B.1.1.7), the South African variant (B.1.351), and the Brazilian variant (P.1). This raised concerns regarding their potential increased virulence and resistance to neutralizing Ab. […]

READ MORE "UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits"




Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

Sentinel Diagnostics is part of the successful companies celebrated by the magazine Forbes Italia, regarding the second edition of the Imprese Vincenti Award (Banca Intesa Sanpaolo). Almost 4.000 companies have applied and, after a careful selection, the committee has chosen the 144 winning companies, which are the best expression of the Italian economic fabric, with revenues […]

READ MORE "Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business"












The new consensus-based recommendations from EAS and EFLM are now available.

The new consensus-based recommendations from EAS and EFLM are now available.

Based on the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, the new consensus-based recommendations from EAS and EFLM are now available. The 2019 ESC/EAS Guidelines recommend the Lp(a) analysis for the population over 40-years-old, in order to identify individuals with a high risk to develop atherosclerotic cardiovascular disease. Clinicians claim that a one-off measurement […]

READ MORE "The new consensus-based recommendations from EAS and EFLM are now available."




Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

  The International Federation of Clinical Chemistry and Laboratory Medicine IFCC has established a Task Force on COVID-19, in order to face the Public Health Emergency. Our CTO NAT Maurizio Gramegna has been selected by IFCC to be one of the Corporate Members of the Task Force on COVID-19, thanks to his long-lasting experience in […]

READ MORE "Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19"




Our FOB Gold® system is the perfect partner for an efficient screening program

Our FOB Gold® system is the perfect partner for an efficient screening program

As every year, the Dutch RIVM publishes the report “Monitoring and Evaluation of the Colorectal Cancer Screening Programme”, regarding the CRC Screening Program in the Netherlands, with which the Institute proudly underlines the successful results obtained. This outcome, regards all aspects of the procedure, from the enrollment of citizens, to the intake of samples, to […]

READ MORE "Our FOB Gold® system is the perfect partner for an efficient screening program"








Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready

Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready

Our ready-to-use lyo Real-Time PCR mix for the detection of novel coronavirus disease is ready. We have developed two kits: COVID-19 HK, that follows the Hong Kong protocol and COVID-19 B, based on Berlin protocol. These two kits will assure you the highest sensitivity and specificity. More info available here!    

READ MORE "Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready"